|
|||||
|
|
Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF‐beta signal |
|
| Authors: | Quanrongzi Wang MD Tongfu Yu MD Yifeng Yuan MD Haiwen Zhuang MD Zhaojing Wang MD Xisheng Liu PhD MD Min Feng PhD MD |
| Affiliation: | 1. Department of Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China;2. Key Laboratory of Living Donor Liver Transplantation of Ministry of Public Health, Nanjing, China;3. Department of General Surgery, Drum Tower Affiliated Hospital of Nanjing University Medical School, Nanjing, China |
| Abstract: | |
| Keywords: | regulatory T cells sorafenib hepatocellular carcinoma TGF‐β |